C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2611188
The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism in exon 26 of the MDRl gene, optionally in combination with polymorphisms of the IMPDH2 and IL 10 genes which were found to be associated with this disease.
L'invention concerne un procédé de prédiction de rejet de transplantation rénale aigu par détection d'un polymorphisme dans un exon 26 du gène MDR1, éventuellement en combinaison avec des polymorphismes des gènes IMPDH2 et IL 10 dont on a découvert qu'ils étaient associés à cette maladie.
Essioux Laurent
Foernzler Dorothee
Hashimoto Lara
Lindpaintner Klaus
Rashford Michelle
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Mdr1 snp in acute rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mdr1 snp in acute rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mdr1 snp in acute rejection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1700615